Zambia Healthy Choices Project for Emerging Adults Living With HIV
Adapting mHealth Interventions to Improve Self-management of HIV and Substance Use Among Emerging Adults in Zambia
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Joseph Zulu, PhD
- Phone Number: +260771514511
- Email: josephmumbazulu@gmail.com
Study Contact Backup
- Name: Deogwoon Kim, PhD
- Email: deogwoon.kim13@umassmed.edu
Study Locations
-
-
-
Lusaka, Zambia
- University of Zambia
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Zambian emerging adults living with HIV
Inclusion Criteria:
- Aged between 18 and 24 years
- Report visual analogue scale showing <80% medication adherence in the last month AND problematic/risky alcohol use in the last month
- Speak English, Nyanja, or Bemba
Exclusion Criteria:
- Have a serious cognitive or psychiatric problem that would compromise ability to provide informed consent
- currently enrolled in another HIV intervention study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Standard ART counseling, mHC, and MTM
Participants in this arm will receive standard ART counseling, followed by two mHealth interventions (mHC and MTM) to improve PrEP uptake and adherence.
|
mHC is a four-session computer-delivered intervention based on the Information-Motivation-Behavioral (IMB) model and socioecological model (SEM).
Using motivational interviewing, it tailors content to participants' responses.
Sessions 1 and 2 focus on HIV self-management and alcohol reduction, gauging importance, confidence, and goals.
Strengths, barriers, resources, and strategies are explored.
Sessions 3 and 4 review goals, reinforce importance, confidence, and motivation, and strategize behavior maintenance.
Over two months, participants engage in goal-oriented sessions, promoting sustained behavior change.
Text messages with motivational statements will be sent to participants based on their readiness to change, as assessed during mHC session 1.
The statements promoting HIV self-management and alcohol use reduction will be derived from an MTM library written by Zambian young people living with HIV.
MTM will be delivered to participants daily for two months and weekly for an additional four months at a time that a participant prefers.
All participants will receive one-on-one, face-to-face in clinic.
Standard ART counseling includes the management and treatment of HIV, reproductive health, substance abuse, and mental health.
They will also be counseled about treatment adherence and side-effect management.
|
|
Experimental: Standard ART counseling and mHC
Participants in this arm will receive standard ART counseling, followed by one mHealth intervention (mHC) to improve PrEP uptake and adherence.
|
mHC is a four-session computer-delivered intervention based on the Information-Motivation-Behavioral (IMB) model and socioecological model (SEM).
Using motivational interviewing, it tailors content to participants' responses.
Sessions 1 and 2 focus on HIV self-management and alcohol reduction, gauging importance, confidence, and goals.
Strengths, barriers, resources, and strategies are explored.
Sessions 3 and 4 review goals, reinforce importance, confidence, and motivation, and strategize behavior maintenance.
Over two months, participants engage in goal-oriented sessions, promoting sustained behavior change.
All participants will receive one-on-one, face-to-face in clinic.
Standard ART counseling includes the management and treatment of HIV, reproductive health, substance abuse, and mental health.
They will also be counseled about treatment adherence and side-effect management.
|
|
Experimental: Standard ART counseling and MTM
Participants in this arm will receive standard ART counseling, followed by one mHealth intervention (MTM) to improve PrEP uptake and adherence.
|
Text messages with motivational statements will be sent to participants based on their readiness to change, as assessed during mHC session 1.
The statements promoting HIV self-management and alcohol use reduction will be derived from an MTM library written by Zambian young people living with HIV.
MTM will be delivered to participants daily for two months and weekly for an additional four months at a time that a participant prefers.
All participants will receive one-on-one, face-to-face in clinic.
Standard ART counseling includes the management and treatment of HIV, reproductive health, substance abuse, and mental health.
They will also be counseled about treatment adherence and side-effect management.
|
|
Active Comparator: Standard ART counseling
Participants in this arm will receive standard ART counseling.
|
All participants will receive one-on-one, face-to-face in clinic.
Standard ART counseling includes the management and treatment of HIV, reproductive health, substance abuse, and mental health.
They will also be counseled about treatment adherence and side-effect management.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intervention Acceptability: System Usability Score (SUS)
Time Frame: Month 3
|
SUS is a 10-item, 5-point Likert scale for subjective assessment of usability.
Each item ranges from 1 to 5. Depending on the item, the score is calculated by subtracting either one from the user response or the user response from 5.
Then, the score for each item will be summed and multiplied by 2.5 for the total score.
The overall SUS scores range from 0 to 100.
A score of > 50 indicates that the technology-based interventions are acceptable.
|
Month 3
|
|
Intervention Acceptability: System Usability Score (SUS)
Time Frame: Month 6
|
SUS is a 10-item, 5-point Likert scale for subjective assessment of usability.
Each item ranges from 1 to 5. Depending on the item, the score is calculated by subtracting either one from the user response or the user response from 5.
Then, the score for each item will be summed and multiplied by 2.5 for the total score.
The overall SUS scores range from 0 to 100.
A score of > 50 indicates that the technology-based interventions are acceptable.
|
Month 6
|
|
Intervention Acceptability: Client Satisfaction Questionnaire (CSQ-8)
Time Frame: Month 3
|
CSQ-8 is an 8-item, 4-point Likert scale measuring the construct of global intervention satisfaction.
The total possible composite score ranges from 8 to 32, with higher scores indicating greater acceptability.
|
Month 3
|
|
Intervention Acceptability: Client Satisfaction Questionnaire (CSQ-8)
Time Frame: Month 6
|
CSQ-8 is an 8-item, 4-point Likert scale measuring the construct of global intervention satisfaction.
The total possible composite score ranges from 8 to 32, with higher scores indicating greater acceptability.
|
Month 6
|
|
Intervention Acceptability: Exit Interview
Time Frame: Month 3
|
Participants will be invited to share their experiences with mHC and MTM, including feedback on acceptability, ease of use, suggestions for improvement, and impact on ART adherence and alcohol use reduction.
|
Month 3
|
|
Intervention Feasibility: Number of Responses to MTM
Time Frame: Baseline to Month 6
|
Intervention feasibility will be evaluated by the total number of responses to MTM.
|
Baseline to Month 6
|
|
Intervention Feasibility: Number of mHC Sessions Completed
Time Frame: Baseline to Month 6
|
Intervention feasibility will be evaluated by the number of completed intervention sessions.
|
Baseline to Month 6
|
|
ART Adherence: Visual Analog Scale
Time Frame: Baseline, Month 3, and Month 6
|
ART adherence will be assessed through the Young Adult Adherence Interview via computer-assisted self-interview (CASI) survey, which contains a visual analog scale (VAS) ranging from 0 to 100.
Higher percentages on the VAS indicate greater adherence to ART.
|
Baseline, Month 3, and Month 6
|
|
ART Adherence: Self-Reported Adherence
Time Frame: Baseline, Month 3, and Month 6
|
ART adherence will be evaluated through self-reported adherence over the past four weeks via a CASI survey.
Participants will rate their adherence on a scale ranging from 0 to 100%, with higher percentages indicating better adherence to ART.
|
Baseline, Month 3, and Month 6
|
|
ART Adherence: Dried Blood Spot (DBS) Testing
Time Frame: Baseline, Month 3, and Month 6
|
ART adherence will be evaluated by examining the HIV viral load in DBS.
Maintaining a viral load of less than 200 copies/ml will indicate adherence to ART.
|
Baseline, Month 3, and Month 6
|
|
Alcohol Use: The Timeline Followback (TLFB) Interview
Time Frame: Baseline, Month 3, and Month 6
|
Alcohol use will be assessed using the TLFB interview.
Using a calendar, participants will be asked to provide estimates of their daily drinking over the last 30 days, as well as the max number of drinks in a one-week period, the number of heavy drinking days, the number of standard drinks in 30 days, and binge drinking.
|
Baseline, Month 3, and Month 6
|
|
Intervention Feasibility: Participant Retention
Time Frame: Baseline to Month 6
|
Intervention feasibility will be assessed based on participant retention at Month 6.
The retention rate can range from 70 to 90%, with a retention rate of over 85% deemed the minimum criterion for feasibility.
|
Baseline to Month 6
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Information: HIV Knowledge
Time Frame: Baseline, Month 3, and Month 6
|
HIV transmission risk awareness will be evaluated through an 18-item HIV Knowledge Questionnaire.
Total possible composite scores range from 0 to 18, with higher scores indicating a higher level of HIV knowledge.
|
Baseline, Month 3, and Month 6
|
|
Information: ART Knowledge
Time Frame: Baseline, Month 3, and Month 6
|
ART knowledge will be evaluated through a 21-item HIV Treatment Knowledge Questionnaire.
Total possible composite scores range from 0 to 21, with higher scores indicating a higher level of ART knowledge.
|
Baseline, Month 3, and Month 6
|
|
Motivation: Rollnick's Readiness Ruler
Time Frame: Baseline, Month 3, and Month 6
|
Intentions to improve HIV self-management and alcohol consumption behaviors will be evaluated using the 5-item Rollnick's Readiness Ruler.
Each item ranges from 0 to 10, with higher scores indicating a greater readiness for change.
|
Baseline, Month 3, and Month 6
|
|
Motivation: Decisional Balance for Problem Behavior
Time Frame: Baseline, Month 3, and Month 6
|
Attitudes toward risk behaviors will be assessed using the 32-item Decisional Balance for Problem Behavior scale.
This 5-point Likert scale evaluates the perceived pros and cons of engaging in risk behaviors
|
Baseline, Month 3, and Month 6
|
|
Sexual Risk
Time Frame: Baseline, Month 3, and Month 6
|
Sexual risk will be assessed using TLFB interview via CASI, capturing sexual behavior over the past 30 days, such as condom usage and the number of sexual partners.
|
Baseline, Month 3, and Month 6
|
|
Drug Use: Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)
Time Frame: Baseline, Month 3, and Month 6
|
Drug use will be assessed with ASSIST, which is a questionnaire to identify substance use health risks and disorders, with each item scored from 0 to 12.
The total score ranges up to 24, with higher scores indicating greater risk based on current substance use patterns.
|
Baseline, Month 3, and Month 6
|
|
Drug Use: Alcohol Use Disorder Identification Text (AUDIT-C)
Time Frame: Baseline, Month 3, and Month 6
|
Alcohol use will be assessed by using AUDIT-C to identify individuals with hazardous drinking habits or alcohol use disorders.
Each item scores from 0 to 4, with 0 indicating no alcohol consumption.
The total score maxes out at 12, with higher scores suggesting greater risks of harm.
|
Baseline, Month 3, and Month 6
|
|
Mental health: Brief Symptom Inventory (BSI-18)
Time Frame: Baseline, Month 3, and Month 6
|
Mental health will be evaluated with BSI-18.
This 18-item questionnaire utilizes a 5-point Likert scale to gauge psychological distress.
Scores range up to 72, with higher scores indicating a higher level of psychological distress.
|
Baseline, Month 3, and Month 6
|
|
Social support: Social Provision Scale
Time Frame: Baseline, Month 3, and Month 6
|
Social support will be evaluated using the Social Provision Scale.
This 5-point Likert scale, 13-item survey assesses the availability of social support, such as emotional, information, and instrumental support, as well as companionship and social isolation.
Scores range up to 65, with higher scores indicating more extensive availability of social support.
|
Baseline, Month 3, and Month 6
|
|
Behavioral Skills: Self-Efficacy
Time Frame: Baseline, Month 3, and Month 6
|
Behavioral skills in HIV self-management will be assessed using a 5-item adapted version of the Self-Efficacy for Health Promotion and Risk Reduction Questionnaire.
This 5-point Likert scale measures confidence levels (score range: 5-25), with higher scores indicating greater confidence in HIV self-management tasks.
|
Baseline, Month 3, and Month 6
|
|
STI Diagnosis: Number of participants who are diagnosed with syphilis, gonorrhea, or chlamydia
Time Frame: Baseline and Month 6
|
Syphilis testing will employ a treponemal test with rapid plasma reagin (RPR), while gonorrhea and chlamydia testing will utilize pooled urine, oropharyngeal, and rectal swabs.
|
Baseline and Month 6
|
|
HIV stigma: Shortened Version of Berger's Stigma Scale
Time Frame: Baseline, Month 3, and Month 6
|
HIV-related stigma will be evaluated using the 10-item Berger's Stigma Scale.
This scale, based on a 4-point Likert scale, assesses the stigma perceived by people living with HIV.
The score can range from 10 to 40, with a higher score indicating greater perceived stigma associated with HIV.
|
Baseline, Month 3, and Month 6
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Bo Wang, PhD, University of Massachusetts, Worcester
Publications and helpful links
General Publications
- Garofalo R, Kuhns LM, Hotton A, Johnson A, Muldoon A, Rice D. A Randomized Controlled Trial of Personalized Text Message Reminders to Promote Medication Adherence Among HIV-Positive Adolescents and Young Adults. AIDS Behav. 2016 May;20(5):1049-59. doi: 10.1007/s10461-015-1192-x.
- Naar-King S, Outlaw AY, Sarr M, Parsons JT, Belzer M, Macdonell K, Tanney M, Ondersma SJ; Adolescent Medicine Network for HIV/AIDS Interventions. Motivational Enhancement System for Adherence (MESA): pilot randomized trial of a brief computer-delivered prevention intervention for youth initiating antiretroviral treatment. J Pediatr Psychol. 2013 Jul;38(6):638-48. doi: 10.1093/jpepsy/jss132. Epub 2013 Jan 28.
- Horvath KJ, Smolenski D, Amico KR. An empirical test of the information-motivation-behavioral skills model of ART adherence in a sample of HIV-positive persons primarily in out-of-HIV-care settings. AIDS Care. 2014 Feb;26(2):142-51. doi: 10.1080/09540121.2013.802283. Epub 2013 Jun 3.
- Cooper V, Clatworthy J, Whetham J, Consortium E. mHealth Interventions To Support Self-Management In HIV: A Systematic Review. Open AIDS J. 2017 Nov 21;11:119-132. doi: 10.2174/1874613601711010119. eCollection 2017.
- Amico KR, Barta W, Konkle-Parker DJ, Fisher JD, Cornman DH, Shuper PA, Fisher WA. The information-motivation-behavioral skills model of ART adherence in a Deep South HIV+ clinic sample. AIDS Behav. 2009 Feb;13(1):66-75. doi: 10.1007/s10461-007-9311-y. Epub 2007 Sep 18.
- Murphy DA, Chen X, Naar-King S, Parsons JT; Adolescent Trials Network. Alcohol and marijuana use outcomes in the Healthy Choices motivational interviewing intervention for HIV-positive youth. AIDS Patient Care STDS. 2012 Feb;26(2):95-100. doi: 10.1089/apc.2011.0157. Epub 2011 Dec 22.
- Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):180-202. doi: 10.1097/QAI.0b013e3181b18b6e.
- Chenneville T, Machacek M, St John Walsh A, Emmanuel P, Rodriguez C. Medication Adherence in 13- to 24-Year-Old Youth Living With HIV. J Assoc Nurses AIDS Care. 2017 May-Jun;28(3):383-394. doi: 10.1016/j.jana.2016.11.002. Epub 2016 Nov 11.
- Nabukeera-Barungi N, Elyanu P, Asire B, Katureebe C, Lukabwe I, Namusoke E, Musinguzi J, Atuyambe L, Tumwesigye N. Adherence to antiretroviral therapy and retention in care for adolescents living with HIV from 10 districts in Uganda. BMC Infect Dis. 2015 Nov 14;15:520. doi: 10.1186/s12879-015-1265-5.
- St Clair-Sullivan N, Mwamba C, Whetham J, Bolton Moore C, Darking M, Vera J. Barriers to HIV care and adherence for young people living with HIV in Zambia and mHealth. Mhealth. 2019 Sep 30;5:45. doi: 10.21037/mhealth.2019.09.02. eCollection 2019.
- Williams EC, Hahn JA, Saitz R, Bryant K, Lira MC, Samet JH. Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions. Alcohol Clin Exp Res. 2016 Oct;40(10):2056-2072. doi: 10.1111/acer.13204. Epub 2016 Sep 22.
- Denison JA, Packer C, Stalter RM, Banda H, Mercer S, Nyambe N, Katayamoyo P, Mwansa JK, McCarraher DR. Factors Related to Incomplete Adherence to Antiretroviral Therapy among Adolescents Attending Three HIV Clinics in the Copperbelt, Zambia. AIDS Behav. 2018 Mar;22(3):996-1005. doi: 10.1007/s10461-017-1944-x.
- Tarantino N, Lowery A, Brown LK. Adherence to HIV Care and Associated Health Functioning among Youth Living with HIV in Sub-Saharan Africa. AIDS Rev. 2020 Jul 8;22(2):93-102. doi: 10.24875/AIDSRev.20000101.
- Scott-Sheldon LA, Carey KB, Cunningham K, Johnson BT, Carey MP; MASH Research Team. Alcohol Use Predicts Sexual Decision-Making: A Systematic Review and Meta-Analysis of the Experimental Literature. AIDS Behav. 2016 Jan;20 Suppl 1(0 1):S19-39. doi: 10.1007/s10461-015-1108-9.
- Mulawa MI, LeGrand S, Hightow-Weidman LB. eHealth to Enhance Treatment Adherence Among Youth Living with HIV. Curr HIV/AIDS Rep. 2018 Aug;15(4):336-349. doi: 10.1007/s11904-018-0407-y.
- Doyle AM, Bandason T, Dauya E, McHugh G, Grundy C, Dringus S, Dziva Chikwari C, Ferrand RA. Mobile Phone Access and Implications for Digital Health Interventions Among Adolescents and Young Adults in Zimbabwe: Cross-Sectional Survey. JMIR Mhealth Uhealth. 2021 Jan 13;9(1):e21244. doi: 10.2196/21244.
- Ramsey SE, Ames EG, Uber J, Habib S, Clark S, Waldrop D. A Preliminary Test of an mHealth Facilitated Health Coaching Intervention to Improve Medication Adherence among Persons Living with HIV. AIDS Behav. 2021 Nov;25(11):3782-3797. doi: 10.1007/s10461-021-03342-5. Epub 2021 Jun 12.
- Hutton A, Prichard I, Whitehead D, Thomas S, Rubin M, Sloand E, Powell TW, Frisch K, Newman P, Goodwin Veenema T. mHealth Interventions to Reduce Alcohol Use in Young People: A Systematic Review of the Literature. Compr Child Adolesc Nurs. 2020 Sep;43(3):171-202. doi: 10.1080/24694193.2019.1616008. Epub 2019 Jun 13.
- Suffoletto B, Chung T, Muench F, Monti P, Clark DB. A Text Message Intervention with Adaptive Goal Support to Reduce Alcohol Consumption Among Non-Treatment-Seeking Young Adults: Non-Randomized Clinical Trial with Voluntary Length of Enrollment. JMIR Mhealth Uhealth. 2018 Feb 16;6(2):e35. doi: 10.2196/mhealth.8530.
- Wang B, MacDonell K, Zulu J, Paul R, Gerber BS, Naar S, Menon JA. Adapting mHealth Interventions to Improve Self-Management of HIV and Reduce Substance Use Among Emerging Adults in Zambia: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2026 Jul 17;15:e99714. doi: 10.2196/99714.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- STUDY00001496
- 1R34DA059935 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.